CoChat

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Neural stem cell-derived extracellular vesicles mitigate Alzheimer’s disease-like phenotypes in a preclinical mouse model

Open access
Gao, Ge, Li, Congcong, Ma, Yizhao, Liang, Zhanping, Li, Yun, Li, Xiangyu, Fu, Shengyang, Wang, Yi, Xia, Xiaohuan, Zheng, Jialin C. · 2023 · Signal Transduction and Targeted Therapy

Abstract

Alzheimer’s disease (AD) is the most common neurodegenerative disorder and the No.1 cause of dementia in elderly with no effective treatments. 1 The application of stem cell-derived extracellular vesicles (EVs) has emerged as a promising therapeutic strategy for AD. 2 EVs are small bilipid layer-enclosed vesicles that display blood-brain barrier (BBB) penetrating ability and similar potency to their parental cells. 2 The administration of EVs derived from neural stem cells (NSCs) and mesenchymal stem cell (MSCs) improved learning and memory functions of AD mice after EVs injection. 2 NSC-derived EVs (NSC-EVs) have been reported to show better effects on improving neural recovery than MSC-derived EVs. 3 However, due to ethical/religious concerns, supply constraints, limited expandability in culture, genetic/phenotypic instability issues, and potential immune responses of allogenic cell secretomes, NSCs may not be an excellent cell source for the production of clinical-grade EVs. Our previous studies obtained mouse fibroblast-derived induced NSCs (iNSCs) through somatic cell reprogramming, opening a new window for obtaining EVs derived from NSC-like cells. 4 , 5 However, whether iNSC-derived (iNSC-EVs) can serve as promising substitutes of NSC-EVs in AD treatment remains unclear.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41392-023-01436-1

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Intravenous administration of NSC-EVs and iNSC-EVs mitigate AD-like phenotypes in 5 × FAD mice. a–d Water maze: a Swim paths of mice while the platform was present (learning phase) or removed (memory phase); b Escape latencies in learning phase; c Platform crossing numbers and swimming distance in the target quadrant in memory phase (n = 9). d Y-maze: novel arm entry numbers and ratios (n = 9). e Open field test: rearing numbers, freezing times, and central field entry numbers (n = 9). f Aβ immunoreactivity in the PFC. g Aβ plaque density and average size were quantified using ImageJ (n = 8). h ELISA assay for the levels of Aβ1-42 in the PFC (n = 6). i pTau immunoreactivity in the PFC. j pTau signal intensity was quantified using ImageJ (n = 7). k Representative images of Golgi-stained PFC tissues (up) and high-power magnification images showing the somata and primary dendrites of neurons (down). l, m The dendritic length (l) and spine density (m) were quantified using ImageJ (n = 9~10). n Heatmap of top 40 DEGs among groups. o, p The top 5 GO terms (o) and KEGG pathways (p) of DEGs in comparison between NSC-EV- and PBS-injected mice. q, r The top 5 GO terms (q) and KEGG pathways (r) of DEGs in comparison between iNSC-EV- and PBS-injected mice. s Iba1 immunoreactivity in the PFC. (t) Numbers of Iba1+ cells were quantified using ImageJ (n = 5). u Iba1 and Aβ immunoreactivities in the PFC. v Numbers of Iba1+ cells around the surface of Aβ plaques were quantified using ImageJ (n = 6). w, x Representative blots (w) and quantification of CD86, IL-1β, and iNOS expression levels (x) in the PFC (n = 3). Scale bar: 200 μm (j, s, u). Error bars denote s.d. ns denotes no significance. *, **, ***, **** denote p < 0.05, p < 0.01, p < 0.001, p < 0.0001, respectively. The statistical difference among groups was assessed with the parametric one-way ANOVA with post-hoc Bonferroni test
Fig. 1 Intravenous administration of NSC-EVs and iNSC-EVs mitigate AD-like phenotypes in 5 × FAD mice. a–d Water maze: a Swim paths of mice while the platform was present (learning phase) or removed (memory phase); b Escape latencies in learning phase; c Platform crossing numbers and swimming distance in the target quadrant in memory phase (n = 9). d Y-maze: novel arm entry numbers and ratios (n = 9). e Open field test: rearing numbers, freezing times, and central field entry numbers (n = 9). f Aβ immunoreactivity in the PFC. g Aβ plaque density and average size were quantified using ImageJ (n = 8). h ELISA assay for the levels of Aβ1-42 in the PFC (n = 6). i pTau immunoreactivity in the PFC. j pTau signal intensity was quantified using ImageJ (n = 7). k Representative images of Golgi-stained PFC tissues (up) and high-power magnification images showing the somata and primary dendrites of neurons (down). l, m The dendritic length (l) and spine density (m) were quantified using ImageJ (n = 9~10). n Heatmap of top 40 DEGs among groups. o, p The top 5 GO terms (o) and KEGG pathways (p) of DEGs in comparison between NSC-EV- and PBS-injected mice. q, r The top 5 GO terms (q) and KEGG pathways (r) of DEGs in comparison between iNSC-EV- and PBS-injected mice. s Iba1 immunoreactivity in the PFC. (t) Numbers of Iba1+ cells were quantified using ImageJ (n = 5). u Iba1 and Aβ immunoreactivities in the PFC. v Numbers of Iba1+ cells around the surface of Aβ plaques were quantified using ImageJ (n = 6). w, x Representative blots (w) and quantification of CD86, IL-1β, and iNOS expression levels (x) in the PFC (n = 3). Scale bar: 200 μm (j, s, u). Error bars denote s.d. ns denotes no significance. *, **, ***, **** denote p < 0.05, p < 0.01, p < 0.001, p < 0.0001, respectively. The statistical difference among groups was assessed with the parametric one-way ANOVA with post-hoc Bonferroni testCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Cited by

See all 46

Metadata

Authors
Gao, G., Li, C., Ma, Y., Liang, Z., Li, Y., Li, X., Fu, S., Wang, Y., Xia, X., & Zheng, J. C.
Affiliations
Tongji University (CN)
Corresponding author
  • Wang, Yi
  • Xia, Xiaohuan
  • Zheng, Jialin C.
Venue
Signal Transduction and Targeted Therapy
Published
2023-06-14
Volume
8
Issue
1
Pages
228-228
ISSN
2059-3635 (ISSN-L)
OpenAlex
W4380538441
Cited by
46
References
5
Citations by year
2026: 12 · 2025: 20 · 2024: 12 · 2023: 2
FWCI
4.10
Type
journal article
Language
en
Open access
Licence
Locations
  • Signal Transduction and Targeted Therapy (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
National Natural Science Foundation of China (81971145, 82271477, 81830037, 91949204)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords
Alzheimer's disease, extracellular vesicles, neural stem cells, induced neural stem cells, somatic cell reprogramming, mesenchymal stem cells, blood-brain barrier, learning and memory, preclinical mouse models
MeSH terms
Alzheimer Disease, Animals, Phenotype, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Neural stem cell-derived extracellular vesicles mitigate Alzheimer’s disease-like phenotypes in a preclinical mouse model. https://app.cochat.ai/papers/10.1038/s41392-023-01436-1
The paper
Gao, G., Li, C., Ma, Y., Liang, Z., Li, Y., Li, X., Fu, S., Wang, Y., Xia, X., & Zheng, J. C. (2023). Neural stem cell-derived extracellular vesicles mitigate Alzheimer’s disease-like phenotypes in a preclinical mouse model. Signal Transduction and Targeted Therapy. https://doi.org/10.1038/s41392-023-01436-1

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.